AC
ALXO icon

Almitas Capital’s ALX Oncology ALXO Stock Holding History

Almitas Capital’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.36M Buy
3,173,834
+636,943
+25% +$1.21M 1.44% 13
2025
Q4 		$2.87M Hold
2,536,891
– – 0.63% 31
2025
Q3 		$4.64M Sell
2,536,891
-1,464
-0.1% -$1.27K 1.06% 19
2025
Q2 		$1.05M Buy
2,538,355
+1,185,214
+88% +$598K 0.27% 45
2025
Q1 		$843K Buy
1,353,141
+130,196
+11% +$156K 0.28% 51
2024
Q4 		$2.04M Buy
+1,222,945
New +$1.88M 0.45% 36

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Almitas Capital's ALXO Position: Q1 2026 in Review

Almitas Capital increased its ALX Oncology (ALXO) stake by 25% in Q1 2026, buying an estimated $1.21M and bringing the position to 3,173,834 shares worth $6.36M. The position accounts for 1.44% of the portfolio, ranked #13.

Almitas Capital first reported a position in ALXO in Q4 2024 and has held it in 6 quarters since. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Almitas Capital held 3,173,834 shares of ALX Oncology worth $6.36M as of Q1 2026.
  • Almitas Capital bought 636,943 ALX Oncology shares in Q1 2026, an estimated $1.21M.
  • ALX Oncology made up 1.44% of Almitas Capital's portfolio in Q1 2026, its #13 holding.
  • Almitas Capital first reported a position in ALX Oncology in Q4 2024 and has held it in 6 quarters since.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Almitas Capital's 13F filing for Q1 2026, filed 15 May 2026.